ArticleOPEN ACCESS

HHT is not a TGFβ disease

Blood
DOI: 10.1182/blood-2007-10-118042
6Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

TGFβ has been considered the most likely ALK1 ligand related to hemorrhagic telangiectasia (HHT). New research reports that TGFβR2 and ALK5 are not required for HHT disease suggesting that HHT might not be a TGFβ subfamily disease.

Cite

CITATION STYLE

APA

Bailly, S. (2008, January 15). HHT is not a TGFβ disease. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2007-10-118042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free